A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
about
Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D RetinoblastomaAn international survey of classification and treatment choices for group D retinoblastoma.Cognitive function and social attainment in adult survivors of retinoblastoma: a report from the St. Jude Lifetime Cohort Study.Long-Term Outcomes of Group B Eyes in Patients with Retinoblastoma Treated with Short-Course Chemoreduction: Experience from Children's Hospital Los Angeles/University of Southern CaliforniaClassification of Vitreous Seeds in Retinoblastoma: Correlations with Patient, Tumor, and Treatment CharacteristicsOrbital implants in retinoblastoma patients: 23 years of experience and a review of the literature.Immunoreactivity of the 14F7 Mab raised against N-Glycolyl GM3 Ganglioside in retinoblastoma tumours.Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis.Safety and efficacy of posterior sub-Tenon's carboplatin injection versus intravitreal melphalan therapy in the management of retinoblastoma with secondary vitreous seeds.Toxic effects of melphalan, topotecan and carboplatin on retinal pigment epithelial cells.Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey
P2860
Q28552363-E5B49314-C52F-48D8-8D18-7D5CE9C0648BQ33914658-B7C9633F-1EA1-41B7-AE55-BA0790F1186CQ34734620-993FE1E7-3607-4A92-953F-3F02E3C8944DQ36843419-17C17999-7554-40A2-9071-FA5FECDB1B98Q37038844-649FBF94-DC40-4EA8-A300-ED3E3201E0BEQ38646638-866C5ED6-281E-40CA-A74F-88E549A9F474Q38939866-5C6484D0-233B-4468-8B4C-9E68B0A24061Q47647048-96135CEC-5D9B-4B8B-A2BC-962A26DEACE1Q51013485-BBEF23AD-A9D8-45D2-8039-982FA71A4871Q52620218-41ABA1F0-3192-479E-84DA-5AF84C667073Q53170879-2E892689-BC17-43D9-8F47-88DC0900A8ACQ58841503-3D9BC8E8-A90B-43B9-971C-D18CDB831C0F
P2860
A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
@en
A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
@nl
type
label
A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
@en
A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
@nl
prefLabel
A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
@en
A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
@nl
P2093
P2860
P356
P1433
P1476
A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
@en
P2093
Charlotta All-Ericsson
Katarina Bartuma
Niklas Pal
Sonja Kosek
Stefan Holm
P2860
P304
P356
10.1111/AOS.12282
P577
2013-10-07T00:00:00Z